200 related articles for article (PubMed ID: 26815386)
1. Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
Cohen JL; Shen Y; Aouadi M; Vangala P; Tencerova M; Amano SU; Nicoloro SM; Yawe JC; Czech MP
Mol Pharm; 2016 Mar; 13(3):964-978. PubMed ID: 26815386
[TBL] [Abstract][Full Text] [Related]
2. Glucan particles for selective delivery of siRNA to phagocytic cells in mice.
Tesz GJ; Aouadi M; Prot M; Nicoloro SM; Boutet E; Amano SU; Goller A; Wang M; Guo CA; Salomon WE; Virbasius JV; Baum RA; O'Connor MJ; Soto E; Ostroff GR; Czech MP
Biochem J; 2011 Jun; 436(2):351-62. PubMed ID: 21418037
[TBL] [Abstract][Full Text] [Related]
3. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
Aouadi M; Tesz GJ; Nicoloro SM; Wang M; Chouinard M; Soto E; Ostroff GR; Czech MP
Nature; 2009 Apr; 458(7242):1180-4. PubMed ID: 19407801
[TBL] [Abstract][Full Text] [Related]
4. Glucan-Encapsulated siRNA Particles (GeRPs) for Specific Gene Silencing in Adipose Tissue Macrophages.
Barreby E; Sulen A; Aouadi M
Methods Mol Biol; 2019; 1951():49-57. PubMed ID: 30825143
[TBL] [Abstract][Full Text] [Related]
5. Glucan-Encapsulated siRNA Particles (GeRPs) for Specific Gene Silencing in Kupffer Cells in Mouse Liver.
Tencerova M
Methods Mol Biol; 2020; 2164():65-73. PubMed ID: 32607884
[TBL] [Abstract][Full Text] [Related]
6. Macrophage specific delivery of TNF-α siRNA complexed with β-1,3-glucan inhibits LPS-induced cytokine production in a murine acute hepatitis model.
Mochizuki S; Morishita H; Sakurai K
Bioorg Med Chem; 2013 May; 21(9):2535-42. PubMed ID: 23523387
[TBL] [Abstract][Full Text] [Related]
7. Protection of shrimp against white spot syndrome virus (WSSV) with β-1,3-D-glucan-encapsulated vp28-siRNA particles.
Zhu F; Zhang X
Mar Biotechnol (NY); 2012 Feb; 14(1):63-8. PubMed ID: 21590271
[TBL] [Abstract][Full Text] [Related]
8. Activated Kupffer cells inhibit insulin sensitivity in obese mice.
Tencerova M; Aouadi M; Vangala P; Nicoloro SM; Yawe JC; Cohen JL; Shen Y; Garcia-Menendez L; Pedersen DJ; Gallagher-Dorval K; Perugini RA; Gupta OT; Czech MP
FASEB J; 2015 Jul; 29(7):2959-69. PubMed ID: 25805830
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages.
Kelly C; Yadav AB; Lawlor C; Nolan K; O'Dwyer J; Greene CM; McElvaney NG; Sivadas N; Ramsey JM; Cryan SA
Mol Pharm; 2014 Nov; 11(11):4270-9. PubMed ID: 25243784
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice.
Aouadi M; Tencerova M; Vangala P; Yawe JC; Nicoloro SM; Amano SU; Cohen JL; Czech MP
Proc Natl Acad Sci U S A; 2013 May; 110(20):8278-83. PubMed ID: 23630254
[TBL] [Abstract][Full Text] [Related]
11. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin small interfering RNA protects mice from fulminant hepatitis.
Saito Y; Kon S; Fujiwara Y; Nakayama Y; Kurotaki D; Fukuda N; Kimura C; Kanayama M; Ito K; Diao H; Matsui Y; Komatsu Y; Ohtsuka E; Uede T
Hum Gene Ther; 2007 Dec; 18(12):1205-14. PubMed ID: 17988193
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Targeted Codelivery of CpG and siRNA by a Dual-Ligand-Functionalized Curdlan Nanoparticle.
Bao Q; Bao M; Xiao H; Ganbold T; Han S; Baigude H
Biomacromolecules; 2024 Jun; 25(6):3360-3372. PubMed ID: 38771665
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal Macrophage-Specific TNF-α Gene Silencing in LPS-Induced Acute Inflammation Model Using CD44 Targeting Hyaluronic Acid Nanoparticles.
Kosovrasti VY; Nechev LV; Amiji MM
Mol Pharm; 2016 Oct; 13(10):3404-3416. PubMed ID: 27552547
[TBL] [Abstract][Full Text] [Related]
15. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
Li H; Zheng X; Koren V; Vashist YK; Tsui TY
Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
[TBL] [Abstract][Full Text] [Related]
18. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticle encapsulated large peritoneal macrophages migrate to the lungs via the systemic circulation in a model of clodronate-mediated lung-resident macrophage depletion.
Oza D; Ivich F; Pace J; Yu M; Niedre M; Amiji M
Theranostics; 2024; 14(6):2526-2543. PubMed ID: 38646640
[No Abstract] [Full Text] [Related]
20. PEGylation of 6-amino-6-deoxy-curdlan for efficient in vivo siRNA delivery.
Altangerel A; Cai J; Liu L; Wu Y; Baigude H; Han J
Carbohydr Polym; 2016 May; 141():92-8. PubMed ID: 26877000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
